Tonix Pharmaceuticals Holding Corp

:TNXP 3:58:45 PM EDT

13.56

+0.32 (+2.42%)

3:59:52 PM EDT: $13.50 -0.06 (-0.44%)

Market Cap (Intraday)	173.41M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$12.95 Million
Adjusted EPS	-$2.58

See more estimates

10-Day MA	$13.77
50-Day MA	$15.61
200-Day MA	$25.82

See more pivots

Tonix Pharmaceuticals Holding Corp Stock, :TNXP

26 Main Street, Suite 101, Chatham, New Jersey 07928

United States of America

Phone: +1.862.799.8599

Number of Employees: 103

http://www.tonixpharma.com

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.